Host genetics of T cell responses and Ad5 titers in the STEP trial A CHAVI - HVTN collaboration. David Goldstein Center for Human Genome Variation, Duke University. Adenovirus 5 serology titers.
Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.
Center for Human Genome Variation, Duke University
Could anti-Ad5 neutralizing antibody titers be merely markers of host genetic factors that confer differential susceptibility to HIV-1?
No significant association in any of the analyses
global survey of the host mechanisms associated with variability in T cell responses to the vaccine
Study population - N=774 trial
HLA Class I associations trial
Duke University trial
Cancer Research Center
Merck Research Laboratories
Harvard Medical School
CHAVI Clinical Core
Clinicians and nurses at Malawi sites